Back to all people

Arunava Chakravartty

Eli Lilly

4 appearances in the program

Sessions & presentations

PS25: Designing Biomarker-Adaptive Trials: Phase II Innovation to Phase III Confirmation

Presentation: Panel discussion (FDA and Pharmaceutical Industry): Regulatory and industry Perspectives on Biomarker-Adaptive Trial Designs

Parallel · Fri, Sep 18 , 8:30 AM

Panelist

PS28: Role of Covariate adjustment in Oncology Trials – Key learnings and opportunities

Parallel · Fri, Sep 18 , 8:30 AM

Organizer

PS28: Role of Covariate adjustment in Oncology Trials – Key learnings and opportunities

Parallel · Fri, Sep 18 , 8:30 AM

Chair

PS10: Strategies to Assess the Impact of Informative Missingness in Regulatory Submissions for Time-to-Event Trials

Parallel · Thu, Sep 17 , 2:45 PM

Organizer

↑